"moderna"

Different types of COVID-19 vaccines have been authorised and it's possible side effects will differ for each.

The AI-assisted method predicted 26 potential vaccines that would work against the coronavirus.

We are encouraged by these new data, which reinforce our confidence that the Moderna Covid-19 vaccine should be protective against these newly detected variants," Stephane Bancel, Chief Executive Officer of Moderna, said in a statement.

The WHO had granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine on December 31, 2020, opening the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.

The company is "fully cooperating" with the California Department of Public Health (CDPH) in investigating these reported adverse events, Moderna said on Tuesday.

We're grateful for all the scientists, researchers, manufacturing workers, and service members, who have worked tirelessly to make this breakthrough possible. It is truly a Christmas miracle, said the US president

A person with knowledge of the negotiations told The Associated Press on Tuesday that the deal is under discussion but has not been finalised.

The European Union is under massive pressure to approve potential vaccines after Britain and the United States began rolling out a drug produced by Pfizer and BioNtech.

New SARS-CoV-2 variant raises questions over efficacy of vaccines

It is more than a sigh of relief as the vaccine that the world was desperately waiting for has finally arrived and more options are on the way

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.

Moderna also confirmed that it expects to have 20 million vaccine doses available in the US by the end of 2020.

The bill, which says the government will cover all vaccine costs for Japan's 126 million residents, was approved by the upper house of parliament, having cleared the powerful lower house.

The scientific head of the US operation to develop a vaccine, Moncef Slaoui said Monday that the green light would probably come in December.

Pfizer said the vaccine had no serious side effects and that the company will apply for emergency use authorization from US regulators "within days"

Developments on vaccine front offer a tentative timeline on when it could be available on a mass scale

Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.